Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Research Fellows 2022

Congratulations to the five 2022 ESMO Research Fellowship awardees    

ESMO Research Fellowships - Translational Focus 2022

Nicole Brighi

Project: High sensitivity bespoke liquid biopsy analysis to characterize and track cabazitaxel-resistant clones in metastatic castration-resistant prostate cancer.
Home institute: IRST - Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRCCS S.r.l., Meldola, Italy
Host institute: University College of London Cancer Institute, London, United Kingdom
Sponsor: ESMO
Expected start date: October 2022

Laetitia Collet

Project: Molecular characterization of intratumor heterogeneity and tumor microenvironment in high grade serous ovarian cancer and BRCA1/2 mutant breast cancers using spatial transcriptomics
Home institute: Université Claude Bernard Lyon 1, Lyon, France
Host institute: Breast Cancer Translational research Laboratory (BCTL), Jules Bordet Institut, Brussels, Belgium
Sponsor: ESMO
Expected start date: November 2022

Santiago Moragon Terencio

Project: Genomic landscape of early-stage luminal breast cancer by single-cell analysis (Tapestri project)
Home institute: Hospital Clinico Universitario de Valencia, Valencia, Spain
Host institute: Gustave Roussy, Villejuif, France
Sponsor: ESMO
Expected start date: October 2023

Anthony Turpin

Project: PARP inhibitors associated tumour immune microenvironment changes in pancreatic ductal adenocarcinoma
Home institute: CHU Lille - Hopital Claude Huriez, Lille, France
Host institute: Vall d'Hebron Institute of Oncology, Barcelona, Spain
Sponsor: ESMO
Expected start date: May 2023

ESMO Research Fellowships - Clinical Focus 2022

Andreas Koulouris

Project: Evaluation of clinical and molecular variables and the development of prognostic tools in patients with advanced non small cell lung cancer (NSCLC) with brain metastases
Home institute: University General Hospital of Heraklion, Heraklion, Greece
Host institute: Karolinska Institutet, Stockholm, Sweden
Sponsor: ESMO
Start date: June 2022

Last update: September 2022

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.